Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 7/2017

01-07-2017 | Original Paper

Combining Text Messaging and Telephone Counseling to Increase Varenicline Adherence and Smoking Abstinence Among Cigarette Smokers Living with HIV: A Randomized Controlled Study

Authors: Tuo-Yen Tseng, Paul Krebs, Antoinette Schoenthaler, Selena Wong, Scott Sherman, Mirelis Gonzalez, Antonio Urbina, Charles M. Cleland, Donna Shelley

Published in: AIDS and Behavior | Issue 7/2017

Login to get access

Abstract

Smoking represents an important health risk for people living with HIV (PLHIV). Low adherence to smoking cessation pharmacotherapy may limit treatment effectiveness. In this study, 158 participants recruited from three HIV care centers in New York City were randomized to receive 12-weeks of varenicline (Chantix) either alone as standard care (SC) or in combination with text message (TM) support or TM plus cell phone-delivered adherence-focused motivational and behavioral therapy (ABT). Generalized linear mixed-effect models found a significant decline in varenicline adherence from week 1–12 across treatment groups. At 12-weeks, the probability of smoking abstinence was significantly higher in SC+TM+ABT than in SC. The study demonstrates the feasibility of delivering adherence-focused interventions to PLHIV who smoke. Findings suggest intensive behavioral support is an important component of an effective smoking cessation intervention for this population, and a focus on improving adherence self-efficacy may lead to more consistent adherence and higher smoking abstinence.
Literature
1.
Burkhalter JE, Springer CM, Chhabra R, et al. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nic Tob Res. 2005;7(4):511–22.CrossRef
2.
Cooperman NA. Current research on cigarette smoking among people with HIV. Curr Addict Rep. 2016;3(1):19–26.CrossRef
3.
Mdodo R, Frazier EL, Dube SR, Mattson CL, Sutton MY, Brooks JT, Skarbinski J. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med. 2015;162(5):335–44.CrossRefPubMed
4.
Sackoff JE, Hanna DB, Pfeiffer MR, et al. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med. 2006;145(6):397–406.CrossRefPubMed
5.
Helleberg M, May MT, Ingle SM, et al. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. AIDS. 2015;29(2):221–9.CrossRefPubMedPubMedCentral
6.
Hile SJ, Feldman MB, Alexy ER, Irvine MK. Recent tobacco smoking is associated with poor HIV medical outcomes among HIV-infected individuals in New York. AIDS Behav. 2016;20(8):1722–9.CrossRefPubMedPubMedCentral
7.
8.
Niaura R, Chander G, Hutton H, Stanton C. Interventions to address chronic disease and HIV: strategies to promote smoking cessation among HIV-infected individuals. Curr HIV/AIDS Rep. 2012;9(4):375–84.CrossRefPubMedPubMedCentral
9.
10.
Shuter J, Morales DA, Considine-Dunn SE, et al. Feasibility and preliminary efficacy of a web-based smoking cessation intervention for HIV-infected smokers: a randomized controlled trial. J Acquir Immune Defic Syndr. 2014;67(1):59–66.CrossRefPubMedPubMedCentral
11.
Vidrine DJ, Marks RM, Arduino RC, et al. Efficacy of cell phone–delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine Tob Res. 2012;14(1):106–10.CrossRefPubMed
12.
Gritz ER, Danysh HE, Fletcher FE, et al. Long-term outcomes of a cell phone-delivered intervention for smokers living with HIV/AIDS. Clin Infect Dis. 2013;57(4):608–15.CrossRefPubMedPubMedCentral
13.
Moadel AB, Bernstein SL, Mermelstein RJ, et al. A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers. J Acquir Immune Defic Syndr. 2012;61(2):208–15.CrossRefPubMedPubMedCentral
14.
Lloyd-Richardson EE, Stanton CA, Papandonatos GD, et al. Motivation and patch treatment for HIV+ smokers: a randomized controlled trial. Addiction. 2009;104(11):1891–900.CrossRefPubMedPubMedCentral
15.
Stanton CA, Papandonatos GD, Shuter J, Bicki A, Lloyd-Richardson EE, de Dios MA, Morrow KM, Makgoeng SB, Tashima KT, Niaura RS. Outcomes of a tailored intervention for cigarette smoking cessation among latinos living with HIV/AIDS. Nicotine Tob Res. 2015;17(8):975–82.CrossRefPubMedPubMedCentral
16.
Ingersoll KS, Cropsey KL, Heckman CJ. A test of motivational plus nicotine replacement interventions for HIV positive smokers. AIDS Behav. 2009;13(3):545–54.CrossRefPubMed
17.
Humfleet GL, Hall SM, Delucchi KL, et al. A randomized clinical trial of smoking cessation treatments provided in HIV clinical care settings. Nicotine Tob Res. 2013;15(8):1436–45.CrossRefPubMedPubMedCentral
18.
Fiore MC, Jaen CR, Baker TB, et al., editors. Treating tobacco use and dependence: 2008 update. Clinical practice guideline. Rockville: U.S. DIANE Publishing; 2008.
19.
Catz SL, Jack LM, McClure JB, et al. Adherence to varenicline in the COMPASS smoking cessation intervention trial. Nicotine Tob Res. 2011;5(5):361–8.CrossRef
20.
Liberman JN, Lichtenfeld MJ, Galaznik A, et al. Adherence to varenicline and associated smoking cessation in a community-based patient setting. J Manag Care Pharm. 2013;19(2):125–31.PubMed
21.
Stanton CA, Lloyd-Richardson EE, Papandonatos GD, et al. Mediators of the relationship between nicotine replacement therapy and smoking abstinence among people living with HIV/AIDS. AIDS Educ Prev. 2009;21(suppl 3):65–80.CrossRefPubMedPubMedCentral
22.
Hays JT, Leischow SJ, Lawrence D, et al. Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence. Nicotine Tob Res. 2010;12(6):574–81.CrossRefPubMed
23.
Raupach T, Brown J, Herbec A, et al. A systematic review of studies assessing the association between adherence to smoking cessation medication and treatment success. Addiction. 2014;109(1):35–43.CrossRefPubMed
24.
Alterman AI, Gariti P, Cook TG, et al. Nicodermal patch adherence and its correlates. Drug Alcohol Depend. 1999;53(2):159–65.CrossRefPubMed
25.
Fucito LM, Toll BA, Salovey P, et al. Beliefs and attitudes about bupropion: Implications for medication adherence and smoking cessation treatment. Psychol Addict Behav. 2009;23(2):373–9.CrossRefPubMedPubMedCentral
26.
Mooney ME, Sayre SL, Hokanson PS, et al. Adding MEMS feedback to behavioral smoking cessation therapy increases compliance with bupropion: a replication and extension study. Addict Behav. 2007;32(4):875–80.CrossRefPubMed
27.
Finitsis DJ, Pellowski JA, Johnson BT. Text message intervention designs to promote adherence to antiretroviral therapy (ART): a meta-analysis of randomized controlled trials. PLoS One. 2014;9(2):e88166.CrossRefPubMedPubMedCentral
28.
Bock B, Heron K, Jennings E, et al. A text message delivered smoking cessation intervention: the initial trial of TXT-2-Quit: randomized controlled trial. JMIR MHealth UHealth. 2013;1(2):e17.CrossRefPubMedPubMedCentral
29.
Bock BC, Heron KE, Jennings EG, et al. User preferences for a text message-based smoking cessation intervention. Health Educ Behav. 2013;40(2):152–9.CrossRefPubMed
30.
Whittaker R, McRobbie H, Bullen C, et al. Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev. 2012; (11).
31.
Spohr SA, Nandy R, Gandhiraj D, et al. Efficacy of SMS text message interventions for smoking cessation: a meta-analysis. J Subst Abuse Treat. 2015;56:1–10.CrossRefPubMed
32.
33.
Bush K, Kihlavan DR, McConell MB, et al. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Arch Int Med. 1998;15(16):1789–95.CrossRef
34.
Heatherton TF, Kozlowski LT, Frecker RC, et al. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989;84(7):791–800.CrossRefPubMed
35.
Bradley KA, DeBenedetti AF, Volk RJ, et al. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res. 2007;31(7):1208–17.CrossRefPubMed
36.
Berman AH, Bergman H, Palmstierna T, et al. Evaluation of the drug use disorders identification test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res. 2005;11(1):22–31.CrossRefPubMed
37.
38.
Fernandez S, Chaplin W, Schoenthaler AM, et al. Revision and validation of the medication adherence self-efficacy scale (MASES) in hypertensive African Americans. J Behav Med. 2008;31(6):453–62.CrossRefPubMedPubMedCentral
39.
Johnson MO, Neilands TB, Dilworth SE, et al. The role of self-efficacy in HIV treatment adherence: validation of the HIV Treatment Adherence Self-Efficacy Scale (HIVASES). J Behav Med. 2007;30(5):359–70.CrossRefPubMedPubMedCentral
40.
Nollen NL, Mayo MS, Ahluwalia JS, et al. Factors associated with discontinuation of bupropion and counseling among African American light smokers in a randomized clinical trial. Ann Behav Med. 2013;46(3):336–48.CrossRefPubMed
41.
Buchanan TA, Carla BJ, Cox LS, et al. Adherence to varenicline among African American smokers: an exploratory analysis comparing plasma concentration, pill count, and self-report. Nicotine Tob Res. 2012;14(9):1083–91.CrossRefPubMedPubMedCentral
42.
Nollen NL, Cox LS, Nazir N, et al. A pilot clinical trial of varenicline for smoking cessation in black smokers. Nicotine Tob Res. 2011;13(9):868–73.CrossRefPubMedPubMedCentral
43.
Fisher JD, Amico KR, Fisher WA, et al. The information-motivation-behavioral skills model of antiretroviral adherence and its applications. Curr HIV/AIDS Rep. 2008;5(4):193–203.CrossRefPubMed
44.
Bandura A. Regulation of cognitive processes through perceived self-efficacy. Dev Psychol. 1989;25(5):729–35.CrossRef
45.
46.
Fisher JD, Fisher WA, Amico KR, et al. An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychol. 2006;25(4):462–73.CrossRefPubMed
47.
Starace F, Massa A, Amico KR, et al. Adherence to antiretroviral therapy: an empirical test of the information-motivation-behavioral skills model. Health Psychol. 2006;25:153–62.CrossRefPubMed
48.
Marlatt GA, Donovan DM, editors. Relapse prevention: maintenance strategies in the treatment of addictive behaviors. New York: Guilford Press; 2005.
49.
50.
Free C, Phillips G, Galli L, et al. The effectiveness of mobile-health technology-based health behaviour change or disease management interventions for health care consumers: a systematic review. PLoS Med. 2013;10(1):e1001362.CrossRefPubMedPubMedCentral
51.
Free C, Whittaker R, Knight R, et al. Txt2stop: a pilot randomised controlled trial of mobile phone-based smoking cessation support. Tob Control. 2009;18(2):88–91.CrossRefPubMed
52.
53.
Lewis MA, Uhrig JD, Bann CM, et al. Tailored text messaging intervention for HIV adherence: a proof-of-concept study. Health Psychol. 2013;32(3):248–53.CrossRefPubMed
54.
Krebs P, Tseng TY, Pham H, et al. Formative evaluation of a text messaging intervention to promote varenicline adherence among tobacco-dependent persons with HIV. J Health Commun. 2015;9:1–5.
55.
Colby SM, Monti PM, Barnett NP, et al. Brief motivational interviewing in a hospital setting for adolescent smoking: a preliminary study. J Consult Clin Psychol. 1998;66(3):574–8.CrossRefPubMed
56.
Hall SM, Muñoz RF, Reus VI. Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. J Consult Clin Psychol. 1994;62(1):141–6.CrossRefPubMed
57.
Miller WR, Wilbourne PL. Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction. 2002;97(3):265–77.CrossRefPubMed
58.
Hollands GJ, McDermott MS, Lindson-Hawley N, et al. Interventions to increase adherence to medications for tobacco dependence. Cochrane Database Syst Rev. 2015; (2).
59.
Bellg AJ, Borrelli B, Resnick B, et al. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH behavior change consortium. Health Psychol. 2004;23(5):443–51.CrossRefPubMed
60.
StataCorp, StataCorp. Stata statistical software: release 14. College Station: StataCorp LP; 2015.
61.
Nakagawa S, Schielzeth H. A general and simple method for obtaining R2 from generalized linear mixed-effects models. Methods Ecol Evol. 2013;4(2):133–42.CrossRef
62.
Lane C, Huws-Thomas M, Hood K, et al. Measuring adaptations of motivational interviewing: the development and validation of the behavior change counseling index (BECCI). Patient Educ Couns. 2005;56(2):166–73.CrossRefPubMed
63.
Hardy H, Kumar V, Doros G, et al. Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy. AIDS Patient Care STDs. 2011;25(3):153–61.PubMedPubMedCentral
64.
Baranoski AS, Meuser E, Hardy H, et al. Patient and provider perspectives on cellular phone-based technology to improve HIV treatment adherence. AIDS Care. 2014;26(1):26–32.CrossRefPubMed
65.
Reynolds NR, Testa MA, Marc LG, et al. Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study. AIDS Behav. 2004;8(2):141–50.CrossRefPubMed
66.
Vidrine DJ, Arduino RC, Lazev AB, et al. A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. Aids. 2006;20(2):253–60.CrossRefPubMed
Metadata
Title
Combining Text Messaging and Telephone Counseling to Increase Varenicline Adherence and Smoking Abstinence Among Cigarette Smokers Living with HIV: A Randomized Controlled Study
Authors
Tuo-Yen Tseng
Paul Krebs
Antoinette Schoenthaler
Selena Wong
Scott Sherman
Mirelis Gonzalez
Antonio Urbina
Charles M. Cleland
Donna Shelley
Publication date
01-07-2017
Publisher
Springer US
Published in
AIDS and Behavior / Issue 7/2017
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-016-1538-z

Other articles of this Issue 7/2017

AIDS and Behavior 7/2017 Go to the issue

Original Paper

Alcohol and HIV Risk Among Russian Women of Childbearing Age

Original Paper

The Association Between Changes in Alcohol Use and Changes in Antiretroviral Therapy Adherence and Viral Suppression Among Women Living with HIV

Original Paper

Phosphatidylethanol (PEth) as a Biomarker of Alcohol Consumption in HIV-Infected Young Russian Women: Comparison to Self-Report Assessments of Alcohol Use

Original Paper

The Role of Current and Historical Alcohol Use in Hepatic Fibrosis Among HIV-Infected Individuals

Original Paper

Objective Measurement of Inaccurate Condom Use Reporting Among Women Using Depot Medroxyprogesterone Acetate for Contraception

Substantive Review

Theoretical and Empirical Comparisons of Methods to Estimate the Size of Hard-to-Reach Populations: A Systematic Review
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits